Vision Consumer Health announces the acquisition of Vision Healthcare NV

Jun 2020 – Vision Consumer Health acquired 100% of the shares of Vision Healthcare NV. Vision Consumer Health is a newly formed entity backed by VHC Investco (regrouping Vision Healthcare’s previous main shareholders), the company’s management and funds managed by Avista Capital Partners.

Vision Healthcare emerged from Damier Group

Dec 2017 – Vision Healthcare has emerged from its parent company Damier Group with a consistent market approach in mind. Vision Healthcare is meant to be a strong and future-oriented vehicle carrying all Damier Group’s self-care and health related brands and companies.

Vision Healthcare announces the acquisition of Medivital BVd

Vision Healthcare acquires the Dutch Medivital BV commercializing the Vitaminen Op Recept brand which offers a subscription-based VMS order model delivering at home at affordable prices and with quality service with key products being eye formula supplement & WLS Sublime (stomach surgery).

Vision Healthcare continues its very fast growth in the D2C healthcare space in Europe and acquires Mylene

Jan 2019 – Vision Healthcare is actively pursuing its buy-and-build strategy operating as a unique consolidator in the European D2C Healthcare landscape whereby the group differentiates itself from a classic B2B retail approach by offering its branded products directly to the end consumer.

Vision Healthcare expands its brand portfolio through the acquisition of Midalgan, Bexedyl and Ostrin

Aug 2018 – Vision Healthcare reached an agreement with the Belgian company Qualiphar NV for the acquisition of a portfolio of brands of which Midalgan, a range of ointments which show beneficial warming and cooling effects for tired, stressed, stiff or cold muscles, is the main product. Midalgan is a strong and well-known brand in the drugstore and pharmacy channels in the Netherlands.

Vision Healthcare acquires VitaminExpress

Apr 2019 – Vision Healthcare acquires VitaminExpress, the German and Austrian leader in the online branded business-to-consumer market of vitamins and nutritional supplements and accelerates its very fast growth in the D2C healthcare space in Europe.

Vision Healthcare announces the acquisition of Sensilab

Apr 2021 – Vision Healthcare announces the acquisition of Sensilab, an Eastern European vitamins, minerals and food supplements (VMS) ecommerce player with excellence in social media marketing and and a retail presence through specialized shops and wholesalers. This acquisition further underlines Vision Healthcare’s geographic expansion and consolidation in existing geographies, enriching the Vision Healthcare group with Sensilab’s online and social media expertise.

Vision Healthcare announces the acquisition of Naturamed Pharma

Dec 2020 – Vision Healthcare announces the acquisition of Naturamed Pharma, a leading Nordics supplier of subscription-based vitamins, minerals and food supplements (“VMS”) products, with a broad customer database with loyal active purchasing. The acquisition creates a foothold in the Nordic D2C VMS markets with commercial synergies potential and allows for further consolidation of the online segment in the Nordics.

Vision Healthcare announces the acquisition of Nutriment AS

Jun 2021 – Vision Healthcare announces the acquisition of Nutriment AS, one of the largest Nordic direct-to-consumer vitamin & nutritional supplement players, offering mainly subscription-based qualitative health products. This acquisition further consolidates VHC’s presence in the Nordic VMS markets, with a large customer base with strong commercial & cost synergies potential.

Vision Healthcare announces the acquisition of AixSwiss

Vision Healthcare reached an agreement with the shareholders of AixSwiss BV for the acquisition of 100% of the shares in AixSwiss BV (“AixSwiss” or the “Company”), a leading DACH e-commerce player active in probiotic nutraceutical supplements commercialised under the “Nupure” brand mainly through its own e-store, Amazon and e-pharma channels.